Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 17;12(11):e0187834.
doi: 10.1371/journal.pone.0187834. eCollection 2017.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada

Affiliations

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada

Sarah A Buchan et al. PLoS One. .

Abstract

Uncertainty remains regarding the magnitude of effectiveness of influenza vaccines for preventing serious outcomes, especially among young children. We estimated vaccine effectiveness (VE) against laboratory-confirmed influenza hospitalizations among children aged 6-59 months. We used the test-negative design in hospitalized children in Ontario, Canada during the 2010-11 to 2013-14 influenza seasons. We used logistic regression models adjusted for age, season, and time within season to calculate VE estimates by vaccination status (full vs. partial), age group, and influenza season. We also assessed VE incorporating prior history of influenza vaccination. We included specimens from 9,982 patient hospitalization episodes over four seasons, with 12.8% testing positive for influenza. We observed variation in VE by vaccination status, age group, and influenza season. For the four seasons combined, VE was 60% (95%CI, 44%-72%) for full vaccination and 39% (95%CI, 17%-56%) for partial vaccination. VE for full vaccination was 67% (95%CI, 48%-79%) for children aged 24-59 months, 48% (95%CI, 12%-69%) for children aged 6-23 months, 77% (95%CI, 47%-90%) for 2010-11, 59% (95%CI, 13%-81%) for 2011-12, 33% (95%CI, -18% to 62%) for 2012-13, and 72% (95%CI, 42%-86%) for 2013-14. VE in children aged 24-59 months appeared similar between those vaccinated in both the current and previous seasons and those vaccinated in the current season only, with the exception of 2012-13, when VE was lower for those vaccinated in the current season only. Influenza vaccination is effective in preventing pediatric laboratory-confirmed influenza hospitalizations during most seasons.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: JBG has received research grants from GSK and Hoffmann-LaRoche for antiviral resistance studies, and from Pfizer Inc. to conduct microbiological surveillance of Streptococcus pneumoniae. AJM has received research funds from GSK and Sanofi-Pasteur. MS has received research grants from Janssen Canada for respiratory virus clinical trials. DT has received research grants from GSK for influenza burden studies and payment for the development of an online course on influenza immunization from Family Physician Airways Group of Canada. All other authors report no conflicts. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Adjusted VE for any vaccination in children aged 24–59 months, by vaccination status during the current and/or the prior influenza seasons, a) by influenza subtype and b) by influenza season.
Vaccine effectiveness estimates are presented for children vaccinated in the current and prior season (circles), the current season only (squares), and the prior season only (triangles).

Similar articles

Cited by

References

    1. Moore DL, Vaudry W, Scheifele DW, Halperin SA, Dery P, Ford-Jones E, et al. Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003–2004. Pediatrics. 2006;118(3):e610–9. doi: 10.1542/peds.2005-2744 - DOI - PubMed
    1. National Advisory Committee on Immunization. Statement on Seasonal Influenza Vaccine for 2012–2013. Can Commun Dis Rep. 2012;38. - PMC - PubMed
    1. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8:CD004879. - PMC - PubMed
    1. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375–85. doi: 10.1093/cid/ciu680 - DOI - PMC - PubMed
    1. Ohmit SE, Petrie JG, Malosh RE, Johnson E, Truscon R, Aaron B, et al. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013–2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. J Infect Dis. 2016;213(8):1229–36. doi: 10.1093/infdis/jiv563 - DOI - PMC - PubMed

Substances